Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tiotropium bromide - Boehringer Ingelheim

Next Previous
X
Search
Drug Profile

Tiotropium bromide - Boehringer Ingelheim

Alternative Names: BA-679-BR; HGP 1011; Spiriva; Spiriva HandiHaler; Spiriva Respimat; Tiotropium; Tiotropium bromide monohydrate; Tiotropium HFA BAI; Tiotropium hydrofluoroalkane breath actuated inhaler; Tiotropium Respimat®

Latest Information Update: 05 Nov 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Boehringer Ingelheim
  • Class Antiasthmatics; Antibronchitics; Epoxy compounds; Esters; Small molecules; Thiophenes; Tropanes
  • Mechanism of Action Muscarinic M1 receptor antagonists; Muscarinic M3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Asthma; Chronic obstructive pulmonary disease
  • Phase III Cystic fibrosis
  • Discontinued Lung cancer

Most Recent Events

  • 30 May 2023 9390521-No update
  • 08 Apr 2021 No recent reports of Phase-III development reported for Asthma (Adjunctive treatment, In children) in Brazil (Inhalation)
  • 29 Aug 2018 Generic equivalent available in western Europe for Chronic obstructive pulmonary disease

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top